Site Search
Search Results
Cancer Advocates Send ‘SOS’ to OK Capitol: Save Our Screenings to Save Lives
OKLAHOMA CITY – Cancer survivors, health professionals and students will convene at the Capitol on Monday, April 16, seeking restoration of the state’s Colorectal Cancer Screening Fund and protection for current life-saving programs. Colorectal cancer is the second deadliest type ... help balance the 2018 budget. The Legislature swept any remaining dollars from the Colorectal Cancer Screening Fund, permanently closing it. Low-cost to no-cost cancer screenings save lives – especially for those who avoid the hospital because of dollar signs at a detriment of their health. Colorectal cancer is a disease that can be treated successfully if found early enough or even prevented altogether with the removal of polyps during a colonoscopy. ACS CAN volunteers ...
Legislation Introduced to Limit Barriers to Breast Cancer Screening, Follows Recent ACS Report Indicating Cancer Rates Rising in Women
A new report released by the American Cancer Society (ACS) last month revealed a shift in the burden of the disease from men to women. Cases of cancer are declining in men while diagnoses are rising in women, specifically younger women. A continued ... legislative proposal include the nonprofit, nonpartisan advocacy affiliate of ACS, the American Cancer Society Cancer Action Network (ACS CAN), and Susan G. Komen For the Cure. One ACS CAN volunteer, a local Pittsburgh breast cancer survivor, is sounding the alarm on the recent report ... free to most insured women starting at age 40, follow-up testing after a suspected or actual abnormal screening often results in out-of-pocket cost sharing for patients. The report showed the out-of-pocket costs across procedures varied across states with Pennsylvania having an average ...
Proposed Legislation Gives Cancer Patients Improved Access to Treatments
Missouri Coalition for Cancer Treatment Access, Wednesday, January 15, 2014: On behalf of thousands of Missouri cancer patients, survivors and their families, the Missouri Coalition for Cancer Treatment Access, applauds the proposed ... of life for our patients and their caregivers, including the convenience of not having to travel several times a week for IV infusions that can take several hours each time,” said Debbie Kersting, Executive Director, The Leukemia & Lymphoma Society – Gateway Chapter. This ... because oral cancer drugs in Missouri are covered as a pharmacy benefit, patients can be charged high co-insurances, up to 50 percent of the cost of the therapy, even if the oral drugs are the only treatment available. This can result in out-of-pocket costs of hundreds to thousands of ...
Protect Funding for Tobacco Prevention and Cessation Programs
Tobacco use remains Texas’ leading preventable cause of death and is the leading cause of cancer deaths in Texas. An estimated 28,000 Texans die annually from tobacco-related illnesses. Texas spends nearly $9 billion in annual ... care costs. And importantly: It will prevent children from becoming addicted adult smokers. During the 2017 Texas Legislative session, ACS CAN was unsuccessful in turning back drastic cuts to tobacco prevention funding at the Department of State Health Services that unfortunately ended ...
Association Health Plan Rule Likely to Divide Insurance Market; Strip Patient Protections
Today the Department of Labor issued final rules governing the creation of association health plans (AHP). Under the rule, AHPs would be exempt from current benefit and cost-sharing requirements. Such plans could, for example, exclude coverage for prescription drugs or other essential health benefits, cap coverage ... could have the same effect as considering someone’s health history. A statement from the American Cancer Society Cancer Action Network (ACS CAN) follows: “This rule will seriously erode the availability of affordable comprehensive coverage in most states’ individual and small group ...
Health Advocates Urge Wyoming Legislature to Pass $1 Tobacco Tax Increase
CHEYENNE, Wyo.—Feb. 13, 2018—Cancer advocates and volunteers from the American Cancer Society Cancer Action Network (ACS CAN) and the American Heart Association gathered in Cheyenne on Tuesday, February 13 for a Day at the Capitol to urge their state lawmakers to ... lawmakers to support the Revenue Committee’s House Bill 43, which would raise Wyoming’s cigarette tax by $1 per pack and increase the price of all other tobacco products like chewing tobacco at equal amounts. The Revenue Committee will introduce HB 43 this week. Each year, 800 Wyoming ... smoking. At current rates, 12,000 Wyoming kids alive today will die prematurely from a tobacco-related illness. "Tobacco use is the top cause of preventable death in our state, and smoking causes nearly 30 percent of all cancer deaths in Wyoming," said Jason Mincer, ACS CAN Wyoming ...
Congress Introduces PSA Screening for HIM Act
... for HIM Act, which would require insurance companies to cover prostate cancer screenings for those at high risk for the disease without out-of-pocket costs. By removing cost barriers for individuals, more people at high risk can receive the necessary screenings to detect prostate cancer in its earliest stages, often before any symptoms of the disease are present. ...
Bipartisan Legislation Would Make It Easier for All Patients to Participate in Clinical Trials
... changes to policy are beneficial to both patients and researchers because they would expand socioeconomic, geographic, and racial diversity of trial participants. A statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN) follows: “ACS CAN is committed to not only increasing patient participation in clinical trials but also ensuring diversification of trial ...
Frequently Asked Questions About Biologic and Biosimilar Drugs
Q. What is a biologic? Answer: Biologics are a class of drugs that are produced using a living system, such as a microorganism, plant cell, or animal cell. Like all drugs, biologics are regulated by ... as the reference product. A biosimilar must have no clinical differences to the reference product. This means that a patient using a biosimilar can expect the same physical responses to the biosimilar as they would to the reference product. A biosimilar is considered highly similar to the ... of biosimilars. In 2010, FDA was given the authority to approve versions of biologic products that would provide competition and likely lower cost alternatives to “brand name” biologics. The biosimilar pathway depends on a head-to-head comparison of the proposed biosimilar to a ...
Press Release: Great American Smokeout
... to Support Tobacco Price Increase Harrisburg, Pennsylvania – Nov. 21, 2013– The American Cancer Society Cancer Action Network (ACS CAN), is celebrating the American Cancer Society’s 38 th annual Great American Smokeout today, by calling on Pennsylvania Lawmakers to protect the health of Pennsylvania residents by increasing the price of tobacco, making it less accessible to young people and more likely for adults to quit. ACS CAN, the advocacy affiliate of the American Cancer ...
Type
- Action (4) Apply Action filter
- Basic page (112) Apply Basic page filter
- Blog Post (85) Apply Blog Post filter
- Event (1) Apply Event filter
- Landing Page (1) Apply Landing Page filter
- Press Release (1167) Apply Press Release filter
- Resource (72) Apply Resource filter
- State Priority (109) Apply State Priority filter
- Update (665) Apply Update filter
Priority Issue
State
- National (239) Apply National filter
- Maine (124) Apply Maine filter
- Massachusetts (120) Apply Massachusetts filter
- New York (117) Apply New York filter
- Vermont (117) Apply Vermont filter
- New Jersey (61) Apply New Jersey filter
- Connecticut (49) Apply Connecticut filter
- Pennsylvania (47) Apply Pennsylvania filter
- Ohio (45) Apply Ohio filter
- California (44) Apply California filter
- Maryland (34) Apply Maryland filter
- Michigan (31) Apply Michigan filter
- North Carolina (31) Apply North Carolina filter
- Florida (29) Apply Florida filter
- Tennessee (26) Apply Tennessee filter
- Kentucky (25) Apply Kentucky filter
- West Virginia (25) Apply West Virginia filter
- New Mexico (24) Apply New Mexico filter
- Illinois (23) Apply Illinois filter
- Texas (23) Apply Texas filter
- Wyoming (23) Apply Wyoming filter
- South Carolina (22) Apply South Carolina filter
- Missouri (21) Apply Missouri filter
- Oklahoma (21) Apply Oklahoma filter
- Colorado (20) Apply Colorado filter
- South Dakota (20) Apply South Dakota filter
- Arizona (19) Apply Arizona filter
- Georgia (19) Apply Georgia filter
- Arkansas (18) Apply Arkansas filter
- Indiana (18) Apply Indiana filter
- Nevada (18) Apply Nevada filter
- Oregon (18) Apply Oregon filter
- New Hampshire (16) Apply New Hampshire filter
- Rhode Island (16) Apply Rhode Island filter
- Montana (15) Apply Montana filter
- Alabama (14) Apply Alabama filter
- Idaho (13) Apply Idaho filter
- Louisiana (13) Apply Louisiana filter
- Minnesota (13) Apply Minnesota filter
- North Dakota (13) Apply North Dakota filter
- Virginia (13) Apply Virginia filter
- Alaska (12) Apply Alaska filter
- Mississippi (11) Apply Mississippi filter
- Nebraska (11) Apply Nebraska filter
- Utah (11) Apply Utah filter
- Kansas (10) Apply Kansas filter
- Washington (10) Apply Washington filter
- Delaware (9) Apply Delaware filter
- District Of Columbia (9) Apply District Of Columbia filter
- Hawaii (9) Apply Hawaii filter
Policy Issue
- Access to Health Care (20) Apply Access to Health Care filter
- Prevention and Early Detection (11) Apply Prevention and Early Detection filter
- Research, Funding and Drug Development (7) Apply Research, Funding and Drug Development filter
- Health Equity (4) Apply Health Equity filter
- Patient Quality of Life (3) Apply Patient Quality of Life filter